Professor Benjamin Thierry is a Research Leader at the Future Industries Institute and the Head of the South Australia Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He has received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Award Fellowships from the NHMRC.
Prof Thierry leads the translational Bioengineering group which aims to develop and implement novel biodiagnostic and prognostic technologies and is currently involved in several clinical translation/commercialization activities. A significant outcome of his research has been the development of a patented cancer staging... Read more
About me
Professor Benjamin Thierry is a Research Leader at the Future Industries Institute and the Head of the South Australia Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He has received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Award Fellowships from the NHMRC.
Prof Thierry leads the translational Bioengineering group which aims to develop and implement novel biodiagnostic and prognostic technologies and is currently involved in several clinical translation/commercialization activities. A significant outcome of his research has been the development of a patented cancer staging diagnostic technology that has received substantial commercial interest and investment through a spin-off company, Ferronova Pty Ltd. With the support of a NHHMRC Dev Grant, a clinical prototype is currently being developed and the pilot clinical trial is scheduled to start in September 2019, which will aim at demonstrating the feasibility and safety of this technology in early-stage oral cancer. A recent research focus has been on the development of biodiagnostic technologies to improve prenatal care. In close collaboration with industry partners and clinicians, he has established a comprehensive research program aimed at enabling better detection of pregnancy complications such as preeclampsia and pre-term birth with a focus on remote/low resource settings. He has also developed and patented a technology aimed at enabling comprehensive non-invasive prenatal genetic testing, which is currently being developed through a spin-off company NIPDx.
Prof Thierry is a Chief Investigator in the ARC Centre of Excellence in Convergent Bio and Nano Science and leads two major research programs of the Centre. The first of this program is focussed on the development of next-generation in vitro organ and disease models, including models based on "organs-on-chips" concept and 3D Bioprinting. With the support of an ARC Linkage grant, intestine-on-chip models developed in his group are being applied to yield better understanding of the intestinal uptake of particulate carriers orally administrated, including oral vaccines. He is also actively collaborating with several water management organisations to utilise these models to study intestinal infections by virus and pathogen. In parallel, cancer-on-chip models are being developed and implemented to assist in the development of better cancer therapeutics, including based on ionizing radiation and immunotherapy. His group has also strong expertise in the design and application of functional nanomaterials. This research theme includes nanoscale solid-state biosensor (supported by an ARC Discovery project in collaboration with Prof Andreas Offenhausser) and nanoparticulate imaging contrast agents (supported by an NHMRC Project grant in collaboration with Prof Eben Rosenthal at Stanford University).
About me
Doctor of Philosophy McGill University
Master of Applied Science Ecole Polytechnique de Montreal
Bachelor of Engineering Institute National Polytechnique de Grenoble
The Nanobioengineering group aims at bridging the gap between engineering and medicine, with a specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
Excludes commercial-in-confidence projects.
Detection and viability of waterborne pathogens using a gut-on-chip, ARC - Linkage Project, 12/12/2018 - 11/12/2021
Preoperative Imaging of Metastatic Deposits in Regional Lymph Nodes: Preclinical Validation of a New Staging Modality for Head and Neck Cancer, NHMRC - Project Grant, 01/01/2019 - 31/07/2021
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC - Centre of Excellence, 01/04/2014 - 29/06/2021
Nanoscale silicon field-effect transistor diagnostic technology, ARC - Discovery Projects, 27/03/2017 - 31/12/2020
Development of Superior Sentinel Lymph Node Mapping Procedures using Magnetic Tracers, NHMRC - Development Grant, 01/01/2019 - 31/12/2020
AAS - Portable Healthcare: High-Value Micro/Nano-Scale Structures and Coating for Mass Production of Biomedical Devices, Australian Academy of Science, 01/11/2017 - 31/10/2020
Development of Superior Sentinel Lymph Node Staging Procedures in Head and Neck Cancer Using Magnetic Tracers, Garnett Passe and Rodney Williams Memorial Foundation - Conjoint Grant, 01/06/2018 - 31/05/2020
Targeting particulate carriers to epithelial M cells, ARC - Linkage Project, 15/12/2015 - 30/09/2019
Advanced technologies for improved molecular diagnostic and prognostic of gastrointestinal cancers, NHMRC - Career Development Fellowship, 01/01/2015 - 31/12/2018
NHMRC Equip 2015 - Stage-top incubator for live-cell imaging with the Zeiss LSM 710 super-high resolution microscope, NHMRC - Equipment Only Grants, 01/01/2016 - 31/12/2016
Nanomedicines Immunotargeting: Hitting the Target or Lost In Translation?, NHMRC - Project Grant, 01/01/2013 - 31/12/2016
A novel nitric oxide-based treatment for recalcitrant Staphylococcus aureus-associated chronic rhinosinusitis (admin by Uni of Adelaide), NHMRC - Project Grant, 01/01/2013 - 30/06/2016
Functional Nanoparticles: Towards Novel Advanced Cancer Diagnostic, Prognostic and Therapeutic Strategies, NHMRC - Career Development Fellowship, 01/01/2010 - 31/12/2014
'The image stream Mark II: a state-of-the-art imaging flow cytometry facility for the detection of rare cancer cells and bioengineering applications, The Ramaciotti Foundations, 15/10/2013 - 14/10/2014
Digital Holographic Microscope: An advanced imaging facility for the development of lab-on-chip devices., The Ramaciotti Foundation - Major Equipment Grant, 01/01/2012 - 31/12/2013
Microfabricated Devices: A significant advance for the detection and molecular analyses of circulating cancer cells?, NHMRC - Project Grant, 01/01/2010 - 31/12/2013
Advanced nanostructured biointerfaces for cell capture, ARC - Discovery Projects, 01/01/2008 - 30/06/2013
Sentinel lymph node biopsy in oesophagel adenocarcinoma - improving staging accuracy & optimising treatment, Cancer Institute NSW, 01/11/2011 - 31/10/2012
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2019 |
|
| 2019 |
58
|
| 2019 |
Open access
2
2
2
|
| 2019 |
|
| 2016 |
Open access
22
22
53
|
| Year | Output |
|---|---|
| 2012 |
|
| 2011 |
|
| 2009 |
|
| Year | Output |
|---|---|
| 2020 |
|
| 2019 |
|
| 2019 |
58
|
| 2019 |
6
|
| 2019 |
1
1
|
| 2019 |
Open access
2
2
2
|
| 2019 |
Open access
|
| 2019 |
|
| 2019 |
2
2
3
|
| 2019 |
|
| 2019 |
Open access
1
1
3
|
| 2019 |
2
1
7
|
| 2018 |
Open access
1
|
| 2018 |
Open access
|
| 2018 |
Open access
1
1
|
| 2018 |
1
1
1
|
| 2018 |
Open access
15
12
8
|
| 2018 |
Open access
7
7
63
|
| 2017 |
Open access
6
6
|
| 2017 |
1
|
| 2017 |
7
8
1
|
| 2017 |
10
9
|
| 2017 |
1
1
|
| 2017 |
|
| 2016 |
Open access
22
22
53
|
| 2016 |
19
16
1
|
| 2016 |
2
|
| 2016 |
Open access
9
7
3
|
| 2016 |
1
2
|
| 2016 |
Open access
13
12
2
|
| 2016 |
15
17
1
|
| 2016 |
12
11
|
| 2015 |
Open access
10
11
|
| 2015 |
26
27
|
| 2015 |
Open access
26
27
2
|
| 2015 |
Open access
59
54
|
| 2015 |
23
22
9
|
| 2015 |
9
10
1
|
| 2015 |
14
12
|
| 2015 |
7
7
|
| 2015 |
Open access
6
5
3
|
| 2014 |
27
27
1
|
| 2014 |
15
16
|
| 2014 |
Open access
10
10
|
| 2014 |
17
17
1
|
| 2014 |
16
15
|
| 2014 |
Open access
23
20
1
|
| 2014 |
1
5
|
| 2014 |
14
13
|
| 2014 |
18
16
|
| 2014 |
19
21
6
|
| 2014 |
4
4
|
| 2014 |
34
30
|
| 2014 |
Open access
10
11
|
| 2014 |
4
3
|
| 2014 |
77
74
1
|
| 2014 |
Open access
39
38
5
|
| 2014 |
22
21
|
| 2014 |
25
23
1
|
| 2013 |
Open access
12
11
|
| 2013 |
23
20
|
| 2012 |
11
8
2
|
| 2012 |
36
34
|
| 2012 |
35
35
|
| 2012 |
25
23
|
| 2011 |
8
8
|
| 2011 |
26
24
9
|
| 2010 |
64
61
|
| 2010 |
120
112
|
| 2010 |
Open access
26
25
|
| 2010 |
38
36
|
| 2010 |
37
33
|
| 2009 |
20
18
|
| 2009 |
56
|
| 2009 |
27
24
|
| 2009 |
24
25
|
| 2009 |
84
84
|
| 2008 |
|
| 2008 |
3
2
|
| 2008 |
64
64
|
| 2008 |
69
67
|
| 2008 |
30
28
|
| Year | Output |
|---|---|
| 2015 |
Open access
|
| 2015 |
1
|
| 2015 |
2
2
|
| 2013 |
2
2
|
Research
The Nanobioengineering group aims at bridging the gap between engineering and medicine, with a specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
| Details | Registry | Status |
|---|---|---|
|
Sensor for detection of magnetic particles Cousins, Aidan Mark Francis; Thierry, Benjamin; Wedding, A Bruce; Forero Morales, Daniel |
WO | Filed |
External engagement & recognition
| Organisation | Country |
|---|---|
| Academia Sinica | TAIWAN |
| Adelaide Pathology Partners | AUSTRALIA |
| Agency for Science, Technology and Research (A*STAR) | SINGAPORE |
| Australian National Fabrication Facility Limited | AUSTRALIA |
| Australian Nuclear Science and Technology Organisation | AUSTRALIA |
| Australian Nuclear Science Technology Organisation | AUSTRALIA |
| Australian Synchrotron Company Ltd | AUSTRALIA |
| Austrian Institute of Technology | SWITZERLAND |
| Bionomics Ltd. | AUSTRALIA |
| Boutiq Science Ltd | NEW ZEALAND |
| Ceramisphere | AUSTRALIA |
| CeramiSphere Pty Ltd | AUSTRALIA |
| Children's Cancer Institute Australia | AUSTRALIA |
| Chinese Academy of Sciences | CHINA |
| CSIRO Australia (Commonwealth Scientific Industrial Research Organisation) | AUSTRALIA |
| Curtin University | AUSTRALIA |
| Dana-Farber Cancer Institute | UNITED STATES |
| ETH Zürich | SWITZERLAND |
| Flinders University | AUSTRALIA |
| Forschungszentrum Jülich | GERMANY |
| Hanson Institute | AUSTRALIA |
| Harbin Institute of Technology | CHINA |
| High Performance Computing | SINGAPORE |
| Imperial College of Science, Technology and Medicine | UNITED KINGDOM |
| Institute of Medical and Veterinary Science | AUSTRALIA |
| Laboratoire de Biologie Moleculaire et de Genie genetique | BELGIUM |
| Marinova Pty Ltd | AUSTRALIA |
| McGill University | CANADA |
| Memorial Sloan Kettering Cancer Centre | UNITED STATES |
| Minomic Pty Ltd | AUSTRALIA |
| Monash IVF Group | AUSTRALIA |
| Monash University | AUSTRALIA |
| Montreal Heart Institute | CANADA |
| Murdoch University | AUSTRALIA |
| Nanjing Agricultural University | CHINA |
| Nanjing Forestry University | CHINA |
| Nanjing Medical University | CHINA |
| Nanyang Technological University | SINGAPORE |
| Peter Grunberg Institute (PGI) | GERMANY |
| Prince of Wales Hospital | AUSTRALIA |
| Private Individual | AUSTRALIA |
| Queen Elizabeth Hospital | AUSTRALIA |
| Queensland University of Technology | AUSTRALIA |
| Repromed | AUSTRALIA |
| RMIT University | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Adelaide Hospital Cancer Centre | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| SA Water Corporation | AUSTRALIA |
| Sechenov First Moscow State Medical University | RUSSIAN FEDERATION |
| Shanghai Jiao Tong University | CHINA |
| Soochow Uiniversity | CHINA |
| Southeast University | CHINA |
| Southern Medical University | CHINA |
| St George Hospital | AUSTRALIA |
| Stanford University | UNITED STATES |
| Sung Kyun Kwan University | KOREA, REPUBLIC OF (SOUTH) |
| Tabriz University of Medical Sciences | IRAN |
| Technical University Munich | GERMANY |
| Universita degli Studi di Pavia (AKA Institute for Advanced Study of Pavia) | ITALY |
| University College Dublin | IRELAND |
| University of Adelaide | AUSTRALIA |
| University of California, Berkeley | UNITED STATES |
| University of Canterbury | NEW ZEALAND |
| University of Edinburgh | UNITED KINGDOM |
| University of Helsinki | FINLAND |
| University of Melbourne | AUSTRALIA |
| University of Montreal | CANADA |
| University of New South Wales | AUSTRALIA |
| University of Nottingham | UNITED KINGDOM |
| University of Oulu | FINLAND |
| University of Pavia | ITALY |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
| University of Tokyo | JAPAN |
| University of Toronto | CANADA |
| University of Warwick | UNITED KINGDOM |
| University of Wisconsin-Madison | UNITED STATES |
| WARTN | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
| Yangzhou University | CHINA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2018 |
Panel member, Early Career Fellowship SchemeNational Health and Medical Research Council (NHMRC) |
2015 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2014 |
Expert panel member, Program Grant SchemeNational Health and Medical Research Council (NHMRC) |
2014 |
Best paper award, Wafer-Scale Fabrication of Ultra-Thin Silicon Nanowire Devices13th IEEE International Conference on Nanotechnology, Beijing |
2013 |
Panel member, Project Grants Peer Review ProcessNational Health and Medical Research Council (NHMRC) |
2012 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2010 |
Prof Thierry is the head of the BioEngineering group at the UniSA Future Industries Institute. The group is hosted in the state-of-the-art MM building and is a dynamic multidisciplinary team with expertise in physics, nanoscience, pharmaceutical science, molecular biology and biomedical engineering. Prof Thierry has a strong network of collaborators and students and ECRs in his group directly benefit from these links which have resulted in long term scientific visits (over 8 weeks and up to 1 year stay) in prestigious international research institutions such as the University of Stanford, the University of Tokyo, the Beijing CAS Centre for Nanoscience and Technology, the Forschungszentrum Juelich, Harvard University Dana-Farber Cancer Institute and McGill University. Several current and dpapst members of the group have received prestigiouss awards, inluding a 2019 Tall Poppy award (Dr. Marnie Winter), a Women in Technology Rising Star Award (Dr Michelle Liu) and a finalist award in the 2018 Prime Minister’s Prizes for Science (Dr Aidan Cousins).
Prof Thierry served as the Program Coordinator of the UniSA NanoBioMaterials Honours degree from 2010 to 2017. He is also teaching in various undergraduate and postgraduate programs, including Monash University and SouthEast University (Nanjing, China).
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Cation exchange reaction in colloidal nanocrystals: a versatile approach towards improved cancer imaging and radiotherapy | Current |
| Characterizing the role of intestinal M cells in the transport of nanoparticles in an advanced microfluidic model of the small intestinal follicle-associated epithelium | Current |
| Development of a lab-on-chip technology for single cell whole genome amplification | Current |
| Development of a wearable electrocardiogram nanosensor for screening hypertensive pregnancy complications | Current |
| Development of nanomedicines for the radiosensitization of proton beam therapy | Current |
| Development of targeted nanocarriers for oral vaccination and or delivery of biologics | Current |
| Functional antigen carrier particles for oral vaccination | Current |
| In vivo manufacturing of CAR-T cells using targeted non-viral nanocarriers | Current |
| Microfluidic intestine-on-a-chip in vitro models for improved understanding of intestinal particulate carrier absorption and interaction with mucus | Current |
| Microfluidic manufacturing of Chimeric Anitgen Receptor T cells | Current |
| Next generation bioengineered in vitro tumour models | Current |
| The role of metal nanoparticles and the metal core/metal oxinde shell structure when utilised as radiosensitisers in X-ray radiation therapy | Current |
| Understanding and targeting preeclampsia molecular mechanisms for improved pregnancy outcomes. | Current |
| Amplification of surface plasmon resonance biomolecular binding events: towards improved biosensing based cancer prognostics | Completed |
| Bioengineered vascularized microfluidic model: towards improved cancer therapy risk reduction and in vitro evaluation of the metastatic process | Completed |
| Detection and characterisation of rare disseminated cancer cells; towards improved patient prognostication | Completed |
| Development of a solid-state biodiagnostic platform based on indium oxide nanoribbon field effect transistors | Completed |
| Formation and characterisation of fucoidan-based polyelectrolyte multilayers for applications in biomaterials | Completed |
| Improving nitric oxide delivery to staphylococcus aureus biofilms | Completed |
| Isolation and analysis of circulating fetal cells: towards improved non-invasive prenatal diagnosis of genetic disorders | Completed |
| Long-range surface plasmon resonance biosensing structures for mammalian-cell studies | Completed |
| Microfluidic intestine-on-a-chip in vitro models for improved mechanistic understanding of intestinal drug and particulate carrier uptake | Completed |
| Novel fabrication and operation of integrated silicon nanowire field effect biosensors for reliable detection of cancer prognostic biomarkers | Completed |
| Novel handheld magnetometer probe for improved intraoperative detection of sentinel lymph nodes in cancer patients | Completed |
| Radiosensitization of cell sub-populations by gold nanoparticles: cross-correlative microscopy for elucidating fundamental mechanisms | Completed |
| Transport of immuno-targeted nanoparticles in 3D tumor spheroids and in vivo models | Completed |